Azmi AS - Search Results

1

Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer.

Al-Hajeili M, Azmi AS, Choi M. Al-Hajeili M, et al. Among authors: azmi as. Onco Targets Ther. 2014 Feb 4;7:187-92. doi: 10.2147/OTT.S40705. eCollection 2014. Onco Targets Ther. 2014. PMID: 24523592 Free PMC article. Review.

2

Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors.

Azmi AS, Banerjee S, Ali S, Wang Z, Bao B, Beck FW, Maitah M, Choi M, Shields TF, Philip PA, Sarkar FH, Mohammad RM. Azmi AS, et al. Oncotarget. 2011 May;2(5):378-92. doi: 10.18632/oncotarget.269. Oncotarget. 2011. PMID: 21623005 Free PMC article.

3

Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.

Azmi AS, Khan HY, Muqbil I, Aboukameel A, Neggers JE, Daelemans D, Mahipal A, Dyson G, Kamgar M, Al-Hallak MN, Tesfaye A, Kim S, Shidham V, M Mohammad R, Philip PA. Azmi AS, et al. Clin Cancer Res. 2020 Mar 15;26(6):1338-1348. doi: 10.1158/1078-0432.CCR-19-1728. Epub 2019 Dec 12. Clin Cancer Res. 2020. PMID: 31831564 Free PMC article. Clinical Trial.

4

Systems biology approaches to pancreatic cancer detection, prevention and treatment.

Alian OM, Philip PA, Sarkar FH, Azmi AS. Alian OM, et al. Among authors: azmi as. Curr Pharm Des. 2014;20(1):73-80. doi: 10.2174/138161282001140113124643. Curr Pharm Des. 2014. PMID: 23530496 Review.

5

Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.

Banerjee S, Azmi AS, Padhye S, Singh MW, Baruah JB, Philip PA, Sarkar FH, Mohammad RM. Banerjee S, et al. Among authors: azmi as. Pharm Res. 2010 Jun;27(6):1146-58. doi: 10.1007/s11095-010-0145-3. Epub 2010 Apr 27. Pharm Res. 2010. PMID: 20422266 Free PMC article.

6

Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Bao B, Azmi AS, Ali S, Zaiem F, Sarkar FH. Bao B, et al. Among authors: azmi as. Ann Transl Med. 2014 Jun;2(6):59. doi: 10.3978/j.issn.2305-5839.2014.06.05. Ann Transl Med. 2014. PMID: 25333034 Free PMC article. Review.

7

Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges.

Diab M, Azmi A, Mohammad R, Philip PA. Diab M, et al. Expert Opin Pharmacother. 2019 Apr;20(5):535-546. doi: 10.1080/14656566.2018.1561869. Epub 2018 Dec 28. Expert Opin Pharmacother. 2019. PMID: 30592647 Review.

8

The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.

Tesfaye AA, Kamgar M, Azmi A, Philip PA. Tesfaye AA, et al. Expert Rev Anticancer Ther. 2018 Feb;18(2):131-148. doi: 10.1080/14737140.2018.1417844. Epub 2017 Dec 19. Expert Rev Anticancer Ther. 2018. PMID: 29254387 Free PMC article. Review.

9

Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy.

Masood A, Azmi AS, Mohammad RM. Masood A, et al. Among authors: azmi as. Cancers (Basel). 2011 Jun 1;3(2):1527-49. doi: 10.3390/cancers3021527. Cancers (Basel). 2011. PMID: 21760983 Free PMC article.

10

Review on molecular and therapeutic potential of thymoquinone in cancer.

Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH, Mohammad RM. Banerjee S, et al. Nutr Cancer. 2010;62(7):938-46. doi: 10.1080/01635581.2010.509832. Nutr Cancer. 2010. PMID: 20924969 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page